Severe adverse cutaneous drug eruptions: Epidemiological and clinical features

International Journal of Dermatology

Volumn 50, Issue 7, 2011, Pages 877-880

  Zaraa, Inès ^a   Jones, Meriem ^a   Trojjet, Sondes ^a   Cheikh Rouhou, Rym ^a   El Euch, Dalenda ^a   Mokni, Mourad ^a   Ben Osman, Amel ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; DRUG ERUPTION; DRUG FATALITY; EOSINOPHILIA; FEMALE; FEVER; HUMAN; LYMPHADENOPATHY; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TUNISIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; CHILD; DRUG ERUPTIONS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEASONS; SEVERITY OF ILLNESS INDEX; TUNISIA; YOUNG ADULT;

EID: 79959584913     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04785.x     Document Type: Article

References (19)

1. Djien V, Bocquet H, Dupuy A, et al. Symptomatology and markers of the severity of erythematous drug eruptions. Ann Dermatol Venereol 1999; 126: 247-250.
2. Hernandez-Salazar A, Ponce-de-Leon Rosales S, Rangel-Frausto S, et al. Epidemiology of adverse cutaneous drug reactions: a prospective study in hospitalized patients. Arch Med Res 2006; 37: 899-902.
3. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1284.
4. Wolf R, Orion E, Marcos B, et al. Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005; 23: 171-181.
5. Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-1022.
6. Davies EC, Green CF, Mottram DR, et al. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335-341.
7. Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of acute cutaneous drug reactions in a scandinavian university hospital. Acta Derm Venereol 2006; 86: 518-522.
8. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304.
9. Roujeau JC. Toxic dermal reactions in the child. Arch Pediatr 2000; 7: 215s-217s.
10. Campos-Fernandez Mdel M, Ponce-De-Leon-Rosales S, Archer-Dubon C, et al. Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit. Rev Invest Clin 2005; 57: 770-774.
11. Sushma M, Noel MV, Ritika MC, et al. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005; 14: 567-570.
12. Stern RS. Utilization of hospital and outpatient care for adverse cutaneous reactions to medications. Pharmacoepidemiol Drug Saf 2005; 14: 677-684.
13. Zanocchi M, Tibaldi V, Amati D, et al. Adverse drug reactions as cause of visit to the emergency department: incidence, features and outcomes. Recenti Prog Med 2006; 97: 381-388.
14. Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177-186.
15. Davies EC, Green CF, Mottram DR, et al. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335-341.
16. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents - a 6 year series from Chandigarh, India. J Postgrad Med 2001; 47: 95-99.
17. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53: 357-379.
18. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-770.
19. Wolkenstein P, Revuz J. Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions. Clin Rev Allergy Immunol 1999; 17: 497-511.